Published in Women's Health Weekly, September 30th, 1996
In a study released in the September 1996 issue of Gynecologic Oncology, physicians using Hybrid Capture technology reliably detected human papillomavirus (HPV) infection on a population of women who had already received abnormal Pap smears. HPV infection can be associated with 93 percent of all cervical cancer cases. The researchers compared these "molecular" findings with the diagnostic gold standard, the cervix biopsy.
The U.S. Food and Drug Administration (FDA)-approved Hybrid Capture test...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly